
MERS 003
A study of a new vaccine against MERS virus in adults aged 50 to 70
You are invited to take part in a study to investigate a new vaccine for Middle East Respiratory Syndrome. The study is being led by the Oxford Vaccine Group which is part of the University of Oxford and is taking place at Liverpool School of Tropical Medicine and Royal Liverpool University Hospital.
If you are aged 50 to 70 years old, in good health and live in the Merseyside area, then you may be eligible to take part. We will provide reimbursement up to a maximum of £360 for your time, inconvenience and travel. Following the first vaccination visit, the total study participation time is 12 months and involves 7 study visits including 2 vaccination visits and 5 follow up visits.

Online Screening Questionnaire
If you would like to find out more, please read the Participant Information Sheet.
If you are interested in joining the study, please visit https://trials.ovg.ox.ac.uk/trials/mers003-online-screening-questionnaire where you can access the online screening questions and register your interest.